Endoplasmic Reticulum Stress in Neurodegenerative Diseases

Dear Colleagues,

Disturbed protein homeostasis is associated with several neurodegenerative disorders such as Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and Alzheimer’s disease, among others. In these disorders, there is an accumulation of misfolded proteins in brain cells leading to counterbalancing signaling including the activation of the unfolded protein response in the endoplasmic reticulum (ER) with the aim to restore homeostasis. However, when prolonged or accentuated, ER stress itself is maladaptive and causes defects in protein turnover, calcium and metabolic dysfunctions, increased oxidative stress, and inflammation responses in the brain ultimately leading to cell death. The precise roles of ER stress in the pathogenesis of the neurodegenerative diseases and the mechanisms how ER stress triggers cell death are, however, not fully understood.

In this Special Issue, a collection of papers by distinguished scientists in the field is presented. ER stress will be discussed from different points of view elucidating both its pathophysiology, the signaling mechanisms involved and the possibilities to interfere with and alleviate the consequences of enhanced ER stress in the different diseases. In addition to protein homeostasis, the emerging roles of ER stress in the regulation of RNA and metabolism will also be highlighted. Together, these results underscore the importance of ER stress and its signaling pathways regulating protein homeostasis to meet various challenges that brain cells encounter during normal life, and which contribute to neurodegenerative disorders and brain ageing. An increased understanding of the mechanisms of ER stress and their relationship with other cellular signaling pathways in brain cells and in various neurodegenerative disorders is crucial for the development of better therapies for these diseases.

Prof. Dr. Dan Lindholm
Prof. Dr. Mart Saarma
Dr. Vera Kovaleva
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• endoplasmic reticulum
• ER stress
• Parkinson’s disease
• Huntington’s disease
• amyotrophic lateral sclerosis
• Alzheimer’s disease
• neurodegenerative disorders